{"id":"W3214093530","doi":"10.1182/blood-2021-153571","title":"A Triplet Combination of Azacitidine, Venetoclax and Gilteritinib for Patients with <i>FLT3</i>-Mutated Acute Myeloid Leukemia: Results from a Phase I/II Study","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Venetoclax; Azacitidine; Medicine; Internal medicine; Decitabine; Chemotherapy regimen; Regimen; Gastroenterology; Myeloid leukemia; Myeloid; Chemotherapy; Leukemia; Oncology; Chemistry","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002625231,0.000241331,0.0006088488,0.0001452675,0.0001377051,0.00002991574,0.0001188992,0.0001230886,0.00002079076],"category_scores_gemma":[0.0004975561,0.0002072504,0.00007048167,0.0004579405,0.00008888073,0.0001248123,0.0001421367,0.0002615347,0.000001896229],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002182736,"about_ca_system_score_gemma":0.000882763,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001648366,"about_ca_topic_score_gemma":0.0000417629,"domain_scores_codex":[0.9978325,0.0001112267,0.0005686737,0.000594075,0.0005415162,0.0003520041],"domain_scores_gemma":[0.9979867,0.0002804714,0.0002166939,0.0004859767,0.0008351261,0.0001950572],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1720062,0.1057501,0.1549555,0.001421807,0.01659542,0.004919323,0.02004737,0.00002114214,0.4697228,0.0002111395,0.01235686,0.04199233],"study_design_scores_gemma":[0.6710501,0.04886094,0.08575512,0.0005337392,0.003295554,0.0001084591,0.001493603,0.0009919174,0.1850684,0.0001394951,0.002088492,0.0006141334],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994366,0.0001015211,0.00006900985,0.0002608157,0.00004558192,0.002325746,0.002579467,0.00005368217,0.000198113],"genre_scores_gemma":[0.9930397,0.00005249442,0.002293464,0.000101635,0.0000752831,0.0001921161,0.00390904,0.00005155191,0.0002846793],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4990439,"threshold_uncertainty_score":0.8451427,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01592817073836526,"score_gpt":0.2888111067648463,"score_spread":0.2728829360264811,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}